Hadassah

Hadassah/Jerusalem Project Inspires UN and Africans to Reduce Spread of AIDS Through Circumcisions

Sunday, Jan 15 2012

Inspired by the Israeli Operation Abraham circumcision project, the United Nations and United States Government are spearheading a program to circumcise 20 million African men over the next five years to help reduce the spread of AIDS.

Circumcision, according to UN data, can reduce the risk of HIV infection by 60 percent. On the heels of Israel's success with circumcising about 100,000 new immigrants from Russia and Ethiopia, Operation Abraham was founded in May 2007 as a collaboration between the Hadassah University Medical Center and the Jerusalem AIDS Project (JAIP). Its first initiative, named "Operation AB" and conducted in Swaziland, marked the beginning of international collaboration in Africa in the area of male circumcision. Operation AB established, pilot tested, and gave shape to a community, clinic-based model for male circumcision training and service delivery.

A delegation of Israeli circumcisors (mohalim) went to Africa at the end of November to help the UN construct medical protocols for this new, broader initiative. Read The Jerusalem Post article.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Jan 11 2018

Hadassah’s Heart Institute: Innovation at the Forefront

Prof. Chaim Lotan, head of the Hadassah Medical Organization’s Heart Institute, has made it a personal objective to foster innovation in cardiovascular technology.

READ MORE ›
alt_text

Thursday, Jan 11 2018

Medical Clown Nehama’s Blog, Chapter Five: Out of Love

“I met Masha in the surgery waiting room at Hadassah Hospital Ein Kerem,” says Medical Clown Shira, as she proceeds to convey this story: Masha is a three-year-old girl who lives in Russia. Every three months, she comes to Hadassah for an oncological examination under full anesthesia.

READ MORE ›
alt_text

Wednesday, Jan 10 2018

Drug Company Collaborates with Hadassah Liver Specialist in Fighting Liver Disease

Dr. Rifaat Safadi, head of the Hadassah Medical Organization’s Liver Unit, in its Institute of Gastroenterology and Liver Diseases, is collaborating with Can-Fite BioPharma Ltd. to explore further the healing effects of a new drug that has proven in preclinical studies to mitigate inflammatory diseases of the liver, such as NASH (non-alcoholic steatohepatitis).

READ MORE ›
alt_text

Wednesday, Jan 10 2018

Bedridden Teen Walks Again, Thanks to First-in-Israel Complex Spinal Surgery at Hadassah

Yusef Rabaya, age 19, spent most of his life in bed at home in Jenin. Born with cerebral palsy (CP), he could sit only if he was propped up. Standing was excruciating and dangerous--and could cause permanent paralysis.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More